DONNA RECTOR: Open Payments
NPI 1790869634 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 40 payments from 17 companies in 2025. Trend: 2023 $956 · 2024 $884 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $213 |
| Lilly USA, LLC | 4 | $91 |
| ABBVIE INC. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Viatris Specialty LLC | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Verona Pharma, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: MOUNJARO, Ozempic, JARDIANCE, Wegovy, YUPELRI, QULIPTA, Rybelsus, UBRELVY.
Industry payments across NY — which companies pay providers there.
